Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Michael A BorgARMed Project Members and Collaborators

Abstract

From January 2003 to December 2005, 5091 susceptibility test results from invasive isolates of Escherichia coli, collected from blood cultures and cerebrospinal fluid routinely processed within 58 participating laboratories, were investigated. These laboratories in turn serviced 64 hospitals in Algeria, Cyprus, Egypt, Jordan, Lebanon, Malta, Morocco, Tunisia and Turkey. The median proportion of resistance to third-generation cephalosporins for the duration of the project was 18.9% (interquartile range (IQR): 12.5-30.8%), and for fluoroquinolones 21.0% (IQR: 7.7-32.6%). A substantial proportion of strains reported by laboratories in countries east of the Mediterranean exhibited evidence of multiresistance, the highest proportion being from Egypt (31%). There is clearly a need for further investigation of potential causes of the significant resistance identified, as well as for strengthening of national and international surveillance initiatives within this region.;

References

Jul 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H BermudesC Quentin
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A C FluitJ Verhoef
Jan 4, 2001·International Journal of Antimicrobial Agents·D Gür, S Unal
Aug 23, 2001·International Journal of Antimicrobial Agents·A C FluitUNKNOWN European SENTRY Participants
Feb 1, 2002·Acta Psychologica·Elisabet Borg, Gunnar Borg
May 9, 2002·Emerging Infectious Diseases·Stephanie J SchragCynthia G Whitney
Mar 5, 2003·The Journal of Antimicrobial Chemotherapy·Amani El KholyDavid L Longworth
Apr 12, 2003·Critical Care Medicine·Daniel P RaymondRobert G Sawyer
Oct 31, 2003·The Journal of Antimicrobial Chemotherapy·David M LivermoreGeorgia Duckworth
Jan 25, 2005·International Journal of Antimicrobial Agents·Gioconda BriganteAntonio Toniolo
Jun 21, 2005·Emerging Infectious Diseases·John M StellingStuart B Levy
Aug 30, 2005·Annals of Emergency Medicine·UNKNOWN National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
Oct 22, 2005·International Journal of Medical Microbiology : IJMM·Heike von Baum, Reinhard Marre
Jul 4, 2006·American Journal of Infection Control·David L Paterson
Jan 20, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ErbH Brenner

❮ Previous
Next ❯

Citations

Jul 26, 2011·Current Infectious Disease Reports·Sumeet Chander, Gerald Coakley
Sep 13, 2011·International Journal of Environmental Research and Public Health·Andreas RousounidisChristos Hadjichristodoulou
Mar 9, 2010·Lancet·Catherine J MathewsGerald Coakley
Mar 15, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Iruka N OkekeKatarina Nordqvist
Jul 9, 2010·Scandinavian Journal of Infectious Diseases·Ase Ostholm-BalkhedLennart E Nilsson
May 21, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mohammad Al-TamimiSaiel Saleh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.